FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Lifts 3 Seladelpar Clinical Holds

FDA lifts clinical holds for trials of three potential indications for CymaBay Therapeutics seladelpar.

Medical Devices

Abbott Patient Controller Approved on iPhone

FDA approves an Abbott PMA to allow use of the companys Patient Controller app on compatible personal Apple smartphone devices.

Human Drugs

Jazz NDA for Daytime Sleepiness Approved

FDA approves a Jazz Pharmaceuticals NDA for Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution for treating cataplexy or excessi...

Human Drugs

FDA Drug Development Tool Qualification Stats

FDA publishes six-month summary statistics for drug development tool qualification projects.

Human Drugs

FDA Wants Doctors to Discuss Naloxone with Patients

FDA says healthcare professionals should discuss naloxone with patients taking opioid pain medicines or drugs for opioid use disorder and consider pre...

Human Drugs

Fresenius Recalls 2 Lots Dexmedetomidine

Fresenius Kabi recalls two lots of dexmedetomidine HCl in 0.9% sodium chloride injection due to the possibility of a trace amount of lidocaine present...

FDA Warns Clinics on Unapproved Covid Cures

FDA and the Federal Trade Commission says Create Wellness Clinics is marketing several types of unapproved products intended to treat Covid-19.

Federal Register

Guide on Human Cell Tissue Products

Federal Register notice: FDA makes available a final guidance entitled Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Bas...

Human Drugs

Dont License Mesoblasts Ryoncil: Petition

A Lassman Law & Policy petition asks FDA to require substantial evidence of effectiveness before approving a BLA for Mesoblasts Ryoncil.

Human Drugs

Positive CDER Response to Liver Safety Biomarker

CDER accepts a C-Path qualification plan for glutamate dehydrogenase as a safety biomarker for drug-induced liver injury.